{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T10:58:42Z","timestamp":1781866722688,"version":"3.54.5"},"reference-count":33,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.3892\/ol.2017.5859","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T08:41:33Z","timestamp":1489480893000},"page":"3205-3209","source":"Crossref","is-referenced-by-count":8,"title":["Immunoexpression of lactoferrin in triple-negative breast cancer patients: A proposal to select a less aggressive subgroup"],"prefix":"10.3892","volume":"13","author":[{"given":"Antonio","family":"Ieni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Barresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Licata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Cardia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Fazzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Nuciforo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Adamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Tuccari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,3,14]]},"reference":[{"key":"key20180108113314_b1-ol-0-0-5859","doi-asserted-by":"crossref","first-page":"R68","DOI":"10.1186\/bcr2635","article-title":"Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer","volume":"12","author":"Prat","year":"2010","journal-title":"Breast Cancer Res"},{"key":"key20180108113314_b2-ol-0-0-5859","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1634\/theoncologist.2011-S1-61","article-title":"Molecular stratification of triple-negative breast cancers","volume":"16","author":"Perou","year":"2011","journal-title":"Oncologist"},{"key":"key20180108113314_b3-ol-0-0-5859","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"J Clin Invest"},{"key":"key20180108113314_b4-ol-0-0-5859","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s13058-014-0406-x","article-title":"PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors","volume":"16","author":"Lehmann","year":"2014","journal-title":"Breast Cancer Res"},{"key":"key20180108113314_b5-ol-0-0-5859","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/sj.bjc.6605735","article-title":"Significance of E-cadherin expression in triple-negative breast cancer","volume":"103","author":"Kashiwagi","year":"2010","journal-title":"Br J Cancer"},{"key":"key20180108113314_b6-ol-0-0-5859","doi-asserted-by":"crossref","first-page":"e0132647","DOI":"10.1371\/journal.pone.0132647","article-title":"Correction: Androgen receptor (AR), E-Cadherin, and Ki-67 as emerging targets and novel prognostic markers in triple-negative breast cancer (TNBC) patients","volume":"10","author":"Ricciardi","year":"2015","journal-title":"PLoS One"},{"key":"key20180108113314_b7-ol-0-0-5859","doi-asserted-by":"crossref","first-page":"612","DOI":"10.5858\/arpa.2014-0122-RA","article-title":"A targetable androgen receptor-positive breast cancer subtype hidden among the triple-negative cancers","volume":"139","author":"Safarpour","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"key20180108113314_b8-ol-0-0-5859","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.anndiagpath.2014.10.003","article-title":"Claudin 4 expression in triple-negative breast cancer: Correlation with androgen receptors and Ki-67 expression","volume":"19","author":"Abd-Elazeem","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"key20180108113314_b9-ol-0-0-5859","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00431665","article-title":"Lactoferrin and lysozyme in carcinomas of the parotid gland. A comparative immunocytochemical study with the occurrence in normal and inflamed tissue","volume":"394","author":"Caselitz","year":"1981","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"key20180108113314_b10-ol-0-0-5859","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF00710558","article-title":"Immunohistochemical demonstration of lactoferrin in follicular adenomas and thyroid carcinomas","volume":"406","author":"Tuccari","year":"1985","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"key20180108113314_b11-ol-0-0-5859","first-page":"347","article-title":"Immunohistochemical demonstration of ceruloplasmin and lactoferrin in a series of 59 thyroid tumors","volume":"12","author":"Cabaret","year":"1992","journal-title":"Ann Pathol"},{"key":"key20180108113314_b12-ol-0-0-5859","first-page":"317","article-title":"Immuno-histochemical detection of lactoferrin in human astrocytomas and multiforme glioblastomas","volume":"43","author":"Tuccari","year":"1999","journal-title":"Eur J Histochem"},{"key":"key20180108113314_b13-ol-0-0-5859","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/ijc.23727","article-title":"Lactotransferrin: A candidate tumor suppressor-Deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway","volume":"123","author":"Zhou","year":"2008","journal-title":"Int J Cancer"},{"key":"key20180108113314_b14-ol-0-0-5859","first-page":"912","article-title":"Immuno-cytochemical detection of lactoferrin in human gastric carcinomas and adenomas","volume":"113","author":"Tuccari","year":"1989","journal-title":"Arch Pathol Lab Med"},{"key":"key20180108113314_b15-ol-0-0-5859","first-page":"1168","article-title":"Malignant transformation of the human endometrium is associated with overexpression of lactoferrin messenger RNA and protein","volume":"55","author":"Walmer","year":"1995","journal-title":"Cancer Res"},{"key":"key20180108113314_b16-ol-0-0-5859","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/(SICI)1098-2744(199710)20:2<240::AID-MC11>3.0.CO;2-A","article-title":"Neoplastic transformation of the endocervix associated with downregulation of lactoferrin expression","volume":"20","author":"Farley","year":"1997","journal-title":"Mol Carcinog"},{"key":"key20180108113314_b17-ol-0-0-5859","first-page":"257","article-title":"Lactoferrin immunoexpression in endometrial carcinomas: Relationships with sex steroid hormone receptors (ER and PR), proliferation indices (Ki-67 and AgNOR) and survival","volume":"16","author":"Giuffr\u00e8","year":"2006","journal-title":"Oncol Rep"},{"key":"key20180108113314_b18-ol-0-0-5859","first-page":"1021","article-title":"Immunoexpression of lactoferrin in human sporadic renal cell carcinomas","volume":"17","author":"Giuffr\u00e8","year":"2007","journal-title":"Oncol Rep"},{"key":"key20180108113314_b19-ol-0-0-5859","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4081\/924","article-title":"Immunolocalization of lactoferrin in surgically resected pigmented skin lesions","volume":"49","author":"Tuccari","year":"2005","journal-title":"Eur J Histochem"},{"key":"key20180108113314_b20-ol-0-0-5859","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s00776-009-1396-x","article-title":"Immuno-localization of lactoferrin in cartilage-forming neoplasms","volume":"14","author":"Ieni","year":"2009","journal-title":"J Orthop Sci"},{"key":"key20180108113314_b21-ol-0-0-5859","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00774-009-0044-z","article-title":"Lactoferrin immuno-expression in human normal and neoplastic bone tissue","volume":"27","author":"Ieni","year":"2009","journal-title":"J Bone Miner Metab"},{"key":"key20180108113314_b22-ol-0-0-5859","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.3892\/ol.2013.1227","article-title":"Immunoexpression of lactoferrin in bone metastases and corresponding primary carcinomas","volume":"5","author":"Ieni","year":"2013","journal-title":"Oncol Lett"},{"key":"key20180108113314_b23-ol-0-0-5859","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1002\/1097-0142(19850601)55:11<2612::AID-CNCR2820551113>3.0.CO;2-C","article-title":"Localization of lactoferrin and nonspecific cross-reacting antigen in human breast carcinomas. An immunohistochemical study using the avidin-biotinperoxidase complex method","volume":"55","author":"Charpin","year":"1985","journal-title":"Cancer"},{"key":"key20180108113314_b24-ol-0-0-5859","doi-asserted-by":"crossref","first-page":"7259","DOI":"10.1158\/0008-5472.CAN-11-1143","article-title":"Lactoferrin endothelin-1 axis contributes to the development and invasiveness of triple-negative breast cancer phenotypes","volume":"71","author":"Ha","year":"2011","journal-title":"Cancer Res"},{"key":"key20180108113314_b25-ol-0-0-5859","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s10534-011-9450-5","article-title":"Lactoferrin in human tumours: Immunohistochemical investigations during more than 25 years","volume":"24","author":"Tuccari","year":"2011","journal-title":"Biometals"},{"key":"key20180108113314_b26-ol-0-0-5859","first-page":"163","article-title":"Lactoferrin expression in human breast cancer","volume":"17","author":"Penco","year":"1999","journal-title":"Cancer Biochem Biophys"},{"key":"key20180108113314_b27-ol-0-0-5859","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/ijc.20728","article-title":"Expression and prognostic value of lactoferrin mRNA isoforms in human breast cancer","volume":"114","author":"Bena\u00efssa","year":"2005","journal-title":"Int J Cancer"},{"key":"key20180108113314_b28-ol-0-0-5859","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4048\/jbc.2016.19.1.96","article-title":"Comments on the \u2018Prognostic impact and clinicopathological correlation of CD133 and ALDH1 expression in invasive breast cancer\u2019","volume":"19","author":"Ieni","year":"2016","journal-title":"J Breast Cancer"},{"key":"key20180108113314_b29-ol-0-0-5859","article-title":"Immunohistochemical Investigation of lactoferrin in human bone primary and metastatic tumours","volume":"1","author":"Ieni","journal-title":"Int J Lab Med Res"},{"key":"key20180108113314_b30-ol-0-0-5859","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3892\/ol.2011.425","article-title":"Morphological and biomolecular characteristics of subcentimetric invasive breast carcinomas in Sicily: A multicentre retrospective study in relation to trastuzumab treatment","volume":"3","author":"Ieni","year":"2012","journal-title":"Oncol Lett"},{"key":"key20180108113314_b31-ol-0-0-5859","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","article-title":"Panel members: Personalizing the treatment of women with early breast cancer: Highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2013","volume":"24","author":"Goldhirsch","year":"2013","journal-title":"Ann Oncol"},{"key":"key20180108113314_b32-ol-0-0-5859","first-page":"157","article-title":"Prognostic value of androgen receptor expression in triple negative breast carcinomas: Personal experience and comments on a review about \u2018Triple-negative breast cancer: Treatment challenges and solutions\u2019 by Collignon et al","volume":"8","author":"Ieni","year":"2016","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"key20180108113314_b33-ol-0-0-5859","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cncr.22381","article-title":"Prognostic markers in triple-negative breast cancer","volume":"109","author":"Rakha","year":"2007","journal-title":"Cancer"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2017.5859\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T15:59:02Z","timestamp":1515427142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2017.5859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,14]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,3,14]]},"published-print":{"date-parts":[[2017,5]]}},"alternative-id":["10.3892\/ol.2017.5859"],"URL":"https:\/\/doi.org\/10.3892\/ol.2017.5859","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,14]]}}}